Juan Young, MD, MHS
Assistant Professor of Psychiatry
Research & Publications
Biography
News
Coauthors
Selected Publications
- Aging gene signature of memory CD8+ T cells is associated with neurocognitive functioning in Alzheimer’s diseaseYoung J, Park H, Kim M, Par-Young J, Bartlett H, Kim H, Unlu S, Osmani L, Shin M, Bucala R, van Dyck C, Allore H, Mecca A, You S, Kang I. Aging gene signature of memory CD8+ T cells is associated with neurocognitive functioning in Alzheimer’s disease. Immunity & Ageing 2023, 20: 71. PMID: 38042785, PMCID: PMC10693128, DOI: 10.1186/s12979-023-00396-y.
- Modulating IL-1β and its receptors shapes spike-specific CD4 +T cell responses to mRNA vaccinationHong-Jai Park, Min Sun Shin, Junghee J Shin, hyoungsu Kim, Byunghyun Kang, Jennefer Par-Young, Serhan Unlu, Yuliya Afinogenova, Jason Catanzaro, Juan Young, Minhyung Kim, Sang Jin Lee, Sungyong You, Michael K Racke, Richard Bucala, Insoo Kang; Modulating IL-1β and its receptors shapes spike-specific CD4 +T cell responses to mRNA vaccination. J Immunol 1 May 2023; 210 (1_Supplement): 159.20. https://doi.org/10.4049/jimmunol.210.Supp.159.20
- Implication of IL-7 receptor alpha chain expression by CD8+ T cells and its signature in defining biomarkers in agingShin M, Park H, Young J, Kang I. Implication of IL-7 receptor alpha chain expression by CD8+ T cells and its signature in defining biomarkers in aging. Immunity & Ageing 2022, 19: 66. PMID: 36544153, PMCID: PMC9768896, DOI: 10.1186/s12979-022-00324-6.
- Validation of a simplified tissue‐to‐reference ratio measurement using SUVR for the assessment of synaptic density alterations in Alzheimer’s disease using [11C]UCB‐J PETO'Dell R, Naganawa M, Toyonaga T, Young J, Dahal R, Singh E, Waheed A, Banks E, Harris J, Chen M, Nabulsi N, Huang Y, Carson R, van Dyck C, Mecca A. Validation of a simplified tissue‐to‐reference ratio measurement using SUVR for the assessment of synaptic density alterations in Alzheimer’s disease using [11C]UCB‐J PET. Alzheimer's & Dementia 2020, 16 DOI: 10.1002/alz.045928.
- USE OF MOCA FOR COGNITIVE SCREENING AMONG NEPALI POPULATIONDahal R, Dahal B, Devkota P, Singh E, Young J, Waheed A. USE OF MOCA FOR COGNITIVE SCREENING AMONG NEPALI POPULATION. American Journal Of Geriatric Psychiatry 2020, 28: s128. DOI: 10.1016/j.jagp.2020.01.159.
- Evidence-Based Pharmacological Management and Treatment of Behavioral and Psychological Symptoms of DementiaYoung J. Evidence-Based Pharmacological Management and Treatment of Behavioral and Psychological Symptoms of Dementia. American Journal Of Psychiatry Residents Journal 2019, 14: 3-5. DOI: 10.1176/appi.ajp-rj.2019.140602.
- Personality and the risk factors for developing behavioral and psychological symptoms of dementia: a narrative reviewYoung JJ, Balachandran S, Garg G, Balasubramaniam M, Gupta A, Tampi DJ, Tampi RR. Personality and the risk factors for developing behavioral and psychological symptoms of dementia: a narrative review. Neurodegenerative Disease Management 2019, 9: 107-118. PMID: 30998118, DOI: 10.2217/nmt-2018-0044.
- Alcohol use disorder: How best to screen and intervene.Dasarathy J, Young J, Chhatlani A, Raddock M, Tampi R. Alcohol use disorder: How best to screen and intervene. The Journal Of Family Practice 2019, 68: 35-39. PMID: 30724900.
- Psychotic disorders in late life: a narrative reviewTampi R, Young J, Hoq R, Resnick K, Tampi D. Psychotic disorders in late life: a narrative review. Therapeutic Advances In Psychopharmacology 2019, 9: 2045125319882798. PMID: 31662846, PMCID: PMC6796200, DOI: 10.1177/2045125319882798.
- Benzodiazepine use and the risk for dementiaTampi R, Tampi D, Young J, Banerjee A. Benzodiazepine use and the risk for dementia. Future Neurology 2018, 13: 209-217. DOI: 10.2217/fnl-2017-0040.
- Cannabinoids for the treatment of behavioral and psychological symptoms of dementiaTampi R, Young J, Tampi D. Cannabinoids for the treatment of behavioral and psychological symptoms of dementia. Neurodegenerative Disease Management 2018, 8: 211-213. PMID: 30040030, DOI: 10.2217/nmt-2018-0019.
- Frontotemporal dementia: latest evidence and clinical implicationsYoung J, Lavakumar M, Tampi D, Balachandran S, Tampi R. Frontotemporal dementia: latest evidence and clinical implications. Therapeutic Advances In Psychopharmacology 2017, 8: 33-48. PMID: 29344342, PMCID: PMC5761910, DOI: 10.1177/2045125317739818.
- Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive DisorderYoung J, Silber T, Bruno D, Galatzer-Levy I, Pomara N, Marmar C. Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder. Frontiers In Psychiatry 2016, 7: 72. PMID: 27199779, PMCID: PMC4843170, DOI: 10.3389/fpsyt.2016.00072.
- A review of the relationship between proinflammatory cytokines and major depressive disorderYoung J, Bruno D, Pomara N. A review of the relationship between proinflammatory cytokines and major depressive disorder. Journal Of Affective Disorders 2014, 169: 15-20. PMID: 25128861, DOI: 10.1016/j.jad.2014.07.032.